| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/10/2002 | CA2435828A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 10/10/2002 | CA2434677A1 Molecules for diagnostics and therapeutics |
| 10/10/2002 | CA2431938A1 A novel vaccine formulation consisting of dna vaccine inactivated virus |
| 10/10/2002 | CA2430684A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto |
| 10/10/2002 | CA2429265A1 Mammalian alpha-helical protein-53 |
| 10/09/2002 | EP1247867A1 Gene encoding plant resistance protein to the tomato mosaic tobamovirus (ToMV) |
| 10/09/2002 | EP1247864A2 58297, an amino acid transporter and uses therefor |
| 10/09/2002 | EP1247863A1 Polypeptide and nucleic acid encoding the same |
| 10/09/2002 | EP1247862A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12) |
| 10/09/2002 | EP1247861A1 Method of examining vulgar psoriasis |
| 10/09/2002 | EP1247817A2 Human CD23-like protein and nucleic acids encoding it |
| 10/09/2002 | EP1247816A1 Immunogen, antivenom and vaccine against the venom of the black widow spider |
| 10/09/2002 | EP1247531A2 TNF-derived peptides for use in treating oedema |
| 10/09/2002 | EP1247530A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12) |
| 10/09/2002 | EP1247103A2 Tethered ligands and methods of use |
| 10/09/2002 | EP1247100A1 Interaction between cd14 and hbv components |
| 10/09/2002 | EP1247099A2 Methods and compositions for detecting hepatitis e virus |
| 10/09/2002 | EP1247095A2 High affinity tcr proteins and methods |
| 10/09/2002 | EP1247094A2 ASSAYS FOR DETECTION OF i BACILLUS ANTHRACIS /i |
| 10/09/2002 | EP1246944A1 PCR-BASED DETECTION OF i RHIZOCTONIA CEREALIS /i |
| 10/09/2002 | EP1246933A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 10/09/2002 | EP1246926A2 Methods of identifying modulators of the fgf receptor |
| 10/09/2002 | EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 10/09/2002 | EP1246923A2 Dna modification proteins |
| 10/09/2002 | EP1246921A2 Increased lysine production by gene amplification using coryneform bacteria |
| 10/09/2002 | EP1246920A2 Prevention of affections associated with porcine circovirus-2 |
| 10/09/2002 | EP1246919A1 Progenitor cell preservation factors and related methods and products |
| 10/09/2002 | EP1246918A2 Secreted proteins |
| 10/09/2002 | EP1246917A2 Human stra6 polypeptides |
| 10/09/2002 | EP1246916A2 26904, 38911, and 39404, seven-transmembrane proteins / g-protein coupled receptors |
| 10/09/2002 | EP1246914A2 Nope polypeptides, encoding nucleic acids and methods of use |
| 10/09/2002 | EP1246910A1 T cell receptor libraries |
| 10/09/2002 | EP1246901A1 Methods for protein transfer |
| 10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/09/2002 | EP1246846A2 Soluble interleukin-20 receptor |
| 10/09/2002 | EP1246845A1 Method for making insulin precursors and insulin precursor analogs |
| 10/09/2002 | EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 10/09/2002 | EP1246843A1 Novel fgf homolog zfgf12 |
| 10/09/2002 | EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 10/09/2002 | EP1246841A1 Transcription factors containing two potential dna binding motifs |
| 10/09/2002 | EP1246840A2 Human and parasite orphan receptor proteins |
| 10/09/2002 | EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 10/09/2002 | EP1246834A1 Epididymal antimicrobial peptides |
| 10/09/2002 | EP1246647A1 Non-immunosuppressant hiv tat |
| 10/09/2002 | EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 10/09/2002 | EP1246644A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 10/09/2002 | EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40 |
| 10/09/2002 | EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia |
| 10/09/2002 | EP1246637A2 Methods of modulation of the immune system |
| 10/09/2002 | EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 10/09/2002 | EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 10/09/2002 | EP1194445A4 Methods for protein purification using aqueous two-phase extraction |
| 10/09/2002 | EP1180160A4 Antibiotic-based gene regulation system |
| 10/09/2002 | EP1105731A4 Profiling and cataloging expressed protein tags |
| 10/09/2002 | EP0979277A4 Novel human tumour suppressor gene |
| 10/09/2002 | EP0960336B1 Peptide reagent for the detection of human cytomegalovirus (cmv) |
| 10/09/2002 | EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient |
| 10/09/2002 | EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
| 10/09/2002 | EP0804562B1 Connective tissue growth factor-2 |
| 10/09/2002 | EP0783521B1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 10/09/2002 | EP0743982B1 Immortalized human fetal osteoblastic cells |
| 10/09/2002 | EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder |
| 10/09/2002 | EP0651761B1 Method for modification of recombinant polypeptides |
| 10/09/2002 | EP0640098B1 Canine coronavirus s gene and uses therefor |
| 10/09/2002 | CN1373807A Mosaic infections bursal disease virus vaccines |
| 10/09/2002 | CN1373805A Antigenic meningococcal peptides |
| 10/09/2002 | CN1373804A Conditional immortalisation of cells |
| 10/09/2002 | CN1373799A Method for producing heterologous secreted protein from Chinese hamster ovary cells grown on microcarriers |
| 10/09/2002 | CN1373774A Compositions isolated from skin cells and methods for their use |
| 10/09/2002 | CN1373773A Polynucleotides encoding human angiotensin-II-1 receptor proteins and method of preparation and its use |
| 10/09/2002 | CN1373772A Gene encoding human huntingtin interacting polypeptide which comprises WW domain and its producing method and application |
| 10/09/2002 | CN1373771A Vaccine |
| 10/09/2002 | CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties |
| 10/09/2002 | CN1373668A Hybrid peptide modulate immune response |
| 10/09/2002 | CN1373220A Coding sequence of human tonB-dependent receptor protein and its preparing process and application |
| 10/09/2002 | CN1373219A Genetic engineering for recombining scorpion venom rBmKaIT1 |
| 10/09/2002 | CN1373218A Inflammatory suppressor factor Fwa 116 |
| 10/09/2002 | CN1373217A Cell multiplication factor Fwap10576 |
| 10/09/2002 | CN1373216A Muscle cell multiplication suppressor factor Fwa267 |
| 10/09/2002 | CN1373141A Gene recombinant fibroblast growth factor-8a polypeptide and method for preparing same |
| 10/09/2002 | CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms |
| 10/08/2002 | US6462256 Nucleic acid molecules from wheat, transgenic plant cells and plants and the thereof for the production of modified starch |
| 10/08/2002 | US6462255 Viral amplification of recombinant messenger RNA in transgenic plants |
| 10/08/2002 | US6462254 Detecting gene expression of fusion proteins |
| 10/08/2002 | US6462189 Fibronectins; monobody loop region varies with wild-type by deletions; binds to specific binding partner |
| 10/08/2002 | US6462188 Drug screening for antiemetic and antipsychotic agents |
| 10/08/2002 | US6462181 Process for preparing a kappa-caseino glycomacropeptide or a derivative thereof |
| 10/08/2002 | US6462180 Precipitation; passing eluted solution through anionic and cationic exchange resins |
| 10/08/2002 | US6462178 G protein |
| 10/08/2002 | US6462177 Mammalian blood loss-induced gene, kd312 |
| 10/08/2002 | US6462176 Apo-3 polypeptide |
| 10/08/2002 | US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 10/08/2002 | US6462172 Purification of tissue plasminogen activator (TPA) |
| 10/08/2002 | US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment |
| 10/08/2002 | US6462170 UPAR mimicking peptide |
| 10/08/2002 | US6462018 Fibrin polymer structure |
| 10/08/2002 | US6462016 Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method |
| 10/08/2002 | US6461867 Synthetic antigen presenting matrix |
| 10/08/2002 | US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis |
| 10/08/2002 | US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity |